Company / CapEx per Share
Cartesian Therapeutics, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.35
FY2025
5-year range
$0.00 / $0.35
FY2021-FY2025
Trend
+824.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +825% YoY in FY2025, a notable deviation from the 7-year average annual change of +350%.
Based on SEC 10-K filings.
0.35 in FY2025 with a 5-year CAGR of +103.0%.
Improved from $0.01 to $0.35 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +276.9%
- 5-Year CAGR
- +103.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- Cartesian Therapeutics, Inc.'s capex per share has grown for 4 consecutive years.
- In FY2025, capex per share increased 824.6% year-over-year.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.35 | +824.6% |
| FY2024 | $0.04 | +438.3% |
| FY2023 | $0.01 | +7.5% |
| FY2022 | $0.01 | +1415.9% |
| FY2021 | $0.00 | -95.8% |
| FY2020 | $0.01 | -68.6% |
| FY2019 | $0.03 | -68.8% |
| FY2016 | $0.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026